Latest News about JNJ
Recent news which mentions JNJ
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
March 27, 2024
From Benzinga
7 Dow Stocks to Buy on the Dip: March 2024
March 27, 2024
From InvestorPlace
What's Going On With Shockwave Medical Stock?
March 26, 2024
From Benzinga
From InvestorPlace
Assessing Johnson & Johnson's Performance Against Competitors In Pharmaceuticals Industry
March 25, 2024
From Benzinga
Nvidia's AI Revolution Is Transforming Healthcare with Johnson & Johnson and GE Healthcare Partnerships
March 25, 2024
From Benzinga
From InvestorPlace
7 Dividend Darlings to Scoop Up Every Time the Market Dips
March 24, 2024
From InvestorPlace
From InvestorPlace
Want Decades of Passive Income? 2 Stocks to Buy Now.
March 22, 2024
From Motley Fool
From InvestorPlace
Johnson & Johnson's Abiomed Unit Recalls Instructions For Some Impella Blood Pumps Due To Cutting Risks
March 21, 2024
From Benzinga
Dear 3M Stock Fans, Mark Your Calendars for April 1
March 21, 2024
From InvestorPlace
From Benzinga
Should You Buy 3M Before April 1?
March 21, 2024
From Motley Fool
From Benzinga
Jim Cramer Reveals Nvidia's Non-Tech Partners That Can Be Potential Market Winner: 'Best Opportunities'
March 19, 2024
From Benzinga
From InvestorPlace
7 Defensive Stocks to Build a Moat Around Your Portfolio
March 19, 2024
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
March 19, 2024
From Benzinga
FDA Adcomm Favors Expanded Use Of Johnson & Johnson, Bristol Myers' CAR-T Therapies For Type Of Blood Cancer
March 18, 2024
From Benzinga
From InvestorPlace
Meet the "Magnificent Seven" Stock That Pays More Dividends Than Any Other U.S.-Based Company
March 16, 2024
From Motley Fool
From Motley Fool
From InvestorPlace
Congressional Scrutiny Intensifies On Chinese Biotech Firms: WuXi AppTec Faces Biotech Exodus
March 14, 2024
From Benzinga
German Conglomerate Bayer Goes Johnson & Johnson Way To Tackle Its Cancer Related Lawsuits
March 14, 2024
From Benzinga
From InvestorPlace
FDA To Review Two Cell Therapies For Multiple Myeloma This Week - Johnson & Johnson And Bristol-Myers
March 13, 2024
From Benzinga
3 No-Brainer Stocks to Buy With $300 Right Now
March 13, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.